Search

everythinglearnresearchcommunity

for

Search:↓

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.

Infrared thermography, especially with dermoscopy, improves accuracy in diagnosing active hair loss due to inflammation.

Low vitamin D levels are common in people with Alopecia Areata.

Modified superoxide dismutase may trigger an autoimmune response in alopecia areata.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Allergies and atopic conditions may increase the risk of developing alopecia areata.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Researchers developed an algorithm for self-diagnosing scalp conditions with high accuracy using smart device-attached microscopes.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

Vitamin D levels are not linked to alopecia areata.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Fractional laser treatment helped hair regrowth in patients with alopecia areata.

Alopecia areata patients have lower zinc, copper, and selenium levels than healthy people.

Wearing wigs or hairpieces improves self-esteem, adaptability, and competence in women with alopecia areata.